A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016)

References

• Hausdorff WP, Hoet B, Adegbola RA. Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough. Expert Rev Vaccines 2015; 14:413-28; PMID:25266168; https://doi.org/10.1586/14760584.2015.965160
   PubMed Web of Science ®Google Scholar
• Deceuninck G, De Serres G, Boulianne N, Lefebvre B, De Wals P. Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada. Vaccine 2015; 33:2684-9; PMID:25887086; https://doi.org/10.1016/j.vaccine.2015.04.005
   PubMed Web of Science ®Google Scholar
• Plosker GL. 13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents. Paediatr Drugs 2013; 15:403-23; PMID:24030738; https://doi.org/10.1007/s40272-013-0047-z
   PubMed Web of Science ®Google Scholar
• Plosker GL. 10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children. Paediatr Drugs 2014; 16:425-44; PMID:25192686; https://doi.org/10.1007/s40272-014-0089-x
   PubMed Web of Science ®Google Scholar
• Bonanni P, Ferro A, Guerra R, Iannazzo S, Odone A, Pompa MG, Rizzuto E, Signorelli C. Vaccine coverage in Italy and assessment of the 2012-2014 National Immunization Prevention Plan. Epidemiol Prev 2015; 39:146-58; PMID:26499433
   PubMed Web of Science ®Google Scholar
• Direção-Geral da Saúde. Boletim Vacinação - PNV - Avaliação 2014. Portugal: Direção-Geral da Saúde; 2015 April [accessed 2016 Dec 15]. http://www.dgs.pt/em-destaque/boletim-de-vacinacao-n9-abril-2015-pdf.aspx
   Google Scholar
• Karanikolos M, Mladovsky P, Cylus J, Thomson S, Basu S, Stuckler D, Mackenbach JP, McKee M. Financial crisis, austerity, and health in Europe. Lancet 2013; 381:1323-31; PMID:23541059; https://doi.org/10.1016/S0140-6736(13)60102-6
   PubMed Web of Science ®Google Scholar
• Direção-Geral da Saúde. Vacinação, a nível hospitalar, contra infecções por Streptococcus pneumoniae de crianças/adolescentes de risco para doença invasiva pneumocócica (DIP). Portugal: Direção-Geral da Saúde; 2010 Jun 12 [accessed 2016 Dec 15]. https://www.dgs.pt/upload/membro.id/ficheiros/i013057.pdf
   Google Scholar
• Direção-Geral da Saúde. Vacinação contra a doença pneumocócica - Prevenar 13® - Pn13. Portugal: Direção-Geral da Saúde; 2015 Jun 30 [accessed 2016 Dec 15]. https://www.dgs.pt/a-direccao-geral-da-saude/comunicados-e-despachos-do-director-geral/vacinacao-contra-a-doenca-pneumococica-prevenar-13-pn13.aspx
   Google Scholar
• Aguiar SI, Brito MJ, Horacio AN, Lopes JP, Ramirez M, Melo-Cristino J, Portuguese Group for the Study of Streptococcal I, Portuguese Study Group of Invasive Pneumococcal Disease of the Paediatric Infectious Disease S. Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012. Euro Surveill 2014; 19:20750; PMID:24698140; https://doi.org/10.2807/1560-7917.ES2014.19.12.20750
   PubMedGoogle Scholar
• Navarro-Torne A, Dias JG, Hruba F, Lopalco PL, Pastore-Celentano L, Gauci AJ, Invasive Pneumococcal Disease Study G. Risk factors for death from invasive pneumococcal disease, Europe, 2010. Emerg Infect Dis 2015; 21:417-25; PMID:25693604; https://doi.org/10.3201/eid2103.140634
   PubMed Web of Science ®Google Scholar
• Vaccine European New Integrated Collaboration Effort. Impact of childhood pneumococcal vaccination programmes and activities for pneumococcal vaccines in the EU and EEA \EFTA countries. VENICE II; 2012 Feb 24 [accessed 2016 Dec 15]. http://venice.cineca.org/VENICE_Survey_PNC_1_2012-02-24.pdf
   Google Scholar
• El portal de las vacunas de la Asociación Española de Pediatría. Recomendaciones de calendario de vacunación infantil para Iberoamérica. Grupo Iberoamericano de Expertos; 2014 June [accessed 2016 Dec 15]. http://vacunasaep.org/sites/vacunasaep.org/files/Recomendaciones_Calendario_Vacunacion_Infantil_Iberoamericano.pdf
   Google Scholar
• Rivero Calle I, Pardo Seco J, Alvez F, Justicia Grande A, Martinon-Sanches JM, Martinon-Torres F. Impact of pneumococcal conjugate vaccination of infants on pneumonia hospitalization in all age groups in Galicia (Spain). Presented at: 34th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2016); 2016 May 10-14; Brighton, UK.
   Google Scholar
• Ruiz-Contreras J, Picazo J, Casado-Flores J, Negreira S, Baquero F, Hernández-Sampelayo T, Otheo E, Del Amo M. IPD evolution in Madrid children by age group before and after the drop of PCV13 vaccination rates: Heracles study (2007-14). Presented at: 33rd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2015) 2015 May 12-16; Leipzig, Germany.
   Google Scholar
• Ministerio de Sanidad Servicios Sociales e Igualdad. Calendario común de Vacunación infantil 2015. Spain: Consejo interterritorial del sistema nacional de salud; 2015 [accessed 2016 Dec 15]. https://www.msssi.gob.es/ciudadanos/proteccionSalud/vacunaciones/docs/CalendarioVacunacion2015.pdf
   Google Scholar
• Boone AL, Beso-Delgado M, Alguacil-Ramos AM, Pastor-Villalba E, Portero-Alonso A, Lluch-Rodrigo JA. Epidemiology and public health system vaccination versus individualized calendar against pneumococcus in the Valencian region, 2015. Presented at: 34th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2016); 2016 May 10-14; Brighton, UK.
   Google Scholar
• Fenoll A, Granizo JJ, Gimenez MJ, Yuste J, Aguilar L. Secular trends (1990-2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination. Vaccine 2015; 33:5691-9; PMID:26341563; https://doi.org/10.1016/j.vaccine.2015.08.009
   PubMed Web of Science ®Google Scholar
• Ruiz-Contreras J, Picazo J, Casado-Flores J, Negreira S, Baquero F, Hernández-Sampelayo T, Otheo E, Del Amo M. IPD incidence rates and serotype evolution following reduction of PCV13 vaccination uptake after switching from universal to private funding in Madrid, Spain: HERACLES study (2007-15). Presented at: 10th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD10); 2016 June 26-30; Glasgow, Scotland.
   Google Scholar
• Picazo J, Ruiz-Contreras J, Casado-Flores J, Negreira S, Garcia-de-Miguel MJ, Hernandez-Sampelayo T, Otheo E, Mendez C, Group HS. Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain. Clin Vaccine Immunol 2013; 20:1524-30; PMID:23925887; https://doi.org/10.1128/CVI.00239-13
   PubMed Web of Science ®Google Scholar
• Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Garcia-de-Miguel MJ, Hernandez-Sampelayo T, Otheo E, Mendez C, Heracles Study G. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011. Pediatr Infect Dis J 2013; 32:656-61; PMID:23249906; https://doi.org/10.1097/INF.0b013e31827e8594
   PubMed Web of Science ®Google Scholar
• Guevara M, Ezpeleta C, Gil-Setas A, Torroba L, Beristain X, Aguinaga A, Garcia-Irure JJ, Navascues A, Garcia-Cenoz M, Castilla J, et al. Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013. Vaccine 2014; 32:2553-62; PMID:24674661; https://doi.org/10.1016/j.vaccine.2014.03.054
   PubMed Web of Science ®Google Scholar
• Guevara M, Barricarte A, Torroba L, Herranz M, Gil-Setas A, Gil F, Bernaola E, Ezpeleta C, Castilla J, Working Group for Surveillance of the Pneumococcal Invasive Disease in Navarra. Direct, indirect and total effects of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children in Navarra, Spain, 2001 to 2014: cohort and case-control study. Euro Surveill 2016; 21: pii = 30186; PMID:27103428; http://dx.doi.org/10.2807/1560-7917.ES.2016.21.14.30186
   Google Scholar
• Picazo J, Duenas J, Ramirez A, Perez AR, Padilla E, Herrero S, Gallegos C, Culebras E, Balseiro C, Mendez C. Incidence of pediatric invasive pneumococcal disease in the Island of Majorca (2008-2010), an area with non-universal vaccination, and estimations of serotype & children population coverage by available conjugate vaccines. BMC Infect Dis 2013; 13:503; PMID:24498901; https://doi.org/10.1186/1471-2334-13-503
   PubMed Web of Science ®Google Scholar
• D'Ancona F, Caporali MG, Del Manso M, Giambi C, Camilli R, D'Ambrosio F, Del Grosso M, Iannazzo S, Rizzuto E, Pantosti A. Invasive pneumococcal disease in children and adults in seven Italian regions after the introduction of the conjugate vaccine, 2008-2014. Epidemiol Prev 2015; 39:134-8; PMID:26499431
   PubMed Web of Science ®Google Scholar
• Il portale dell'epidemiologia per la sanità pubblica. Copertura vaccinale in Italia Italy: Istituto Superiore di Sanità; 2016 Oct 4 [accessed 2016 Dec 15]. http://www.epicentro.iss.it/temi/vaccinazioni/dati_Ita.asp
   Google Scholar
• Istituto Superiore di Sanità. Dati di sorveglianza delle malattie batteriche invasive 2007-2010. Italy: Istituto Superiore di Sanità; 2013 Jun 30 [accessed 2016 Dec 15]. http://www.iss.it/binary/mabi/cont/Report_MBI2_2007_2010.pdf
   Google Scholar
• Istituto Superiore di Sanità. Dati di sorveglianza delle malattie batteriche invasive aggiornati al 30 maggio 2014. Italy: Istituto Superiore di Sanità; 2014 March 30 [accessed 2016 Dec 15]. http://www.iss.it/binary/mabi/cont/Report_MBI_20140919.pdf
   Google Scholar
• Istituto Superiore di Sanità. Dati di sorveglianza delle malattie batteriche invasive aggiornati al 23 marzo 2015. Italy: Istituto Superiore di Sanità; 2015 March 23 [accessed 2016 Dec 15]. http://www.iss.it/binary/mabi/cont/Report_MBI_20150323_V8.pdf
   Google Scholar
• Fortunato F, Martinelli D, Cappelli MG, Cozza V, Prato R. Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children. J Immunol Res 2015; 2015:206757; PMID:26351644; https://doi.org/10.1155/2015/206757
   PubMed Web of Science ®Google Scholar
• Martinelli D, Pedalino B, Cappelli MG, Caputi G, Sallustio A, Fortunato F, Tafuri S, Cozza V, Germinario C, Chironna M, et al. Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013. Hum Vaccin Immunother 2014; 10:33-9; PMID:24096297; https://doi.org/10.4161/hv.26650
   PubMed Web of Science ®Google Scholar
• Amodio E, Bella A, Nicoletti G, Stefani S, Vitale F, Working G. [Active surveillance of invasive pneumococcal diseases in Sicilian children (2009-2011)]. Ig Sanita Pubbl 2013; 69:79-90; PMID:23532162
   PubMedGoogle Scholar
• Baldovin T, Lazzari R, Russo F, Bertoncello C, Buja A, Furlan P, Cocchio S, Palu G, Baldo V. A surveillance system of Invasive Pneumococcal Disease in North-Eastern Italy. Ann Ig 2016; 28:15-24; PMID:26980506
   PubMedGoogle Scholar
• World Health Organization. Immunization, Vaccines and Biologicals - Data, statistics and graphics. World Health Organization; 2016 July 15 [accessed 2016 Sept 7]. http://www.who.int/immunization/monitoring_surveillance/data/en/
   Google Scholar
• Georgakopoulou T, Menegas D, Katsioulis A, Theodoridou M, Kremastinou J, Hadjichristodoulou C. A cross-sectional vaccination coverage study in preschool children attending nurseries-kindergartens. Implications on economic crisis effect. Hum Vaccin Immunother 2016: [Epub ahead of print]; PMID:27669156; https://doi.org/10.1080/21645515.2016.1230577
   PubMed Web of Science ®Google Scholar
• Syrogiannopoulos GA, Michoula AN, Tsimitselis G, Vassiou K, Chryssanthopoulou DC, Grivea IN. Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine. Infect Dis (Lond) 2016; 48:749-53; PMID:27320108; https://doi.org/10.1080/23744235.2016.1192720
   PubMed Web of Science ®Google Scholar
• National School of Public Health. National Meningitis Reference Laboratory Data 1993-2014. Greece: G. Tzanakaki; 2014 [accessed 2016 Dec 15]. http://www.nsph.gr/files/001_Dimosias_Dioikitikis_Ygieinis/EKAM/ApologismoiEKAM/Apol-2014.pdf
   Google Scholar
• National School of Public Health. National Meningitis Reference Laboratory Data 1993-2015. Greece: G. Tzanakaki; 2015 [accessed 2016 Dec 15]. http://www.nsph.gr/files/001_Dimosias_Dioikitikis_Ygieinis/EKAM/ApologismoiEKAM/Apol-2015-1.pdf
   Google Scholar
• WHO. Pneumococcal vaccines WHO position paper-2012. Wkly Epidemiol Rec 2012; 87:129-44; PMID:24340399
   PubMedGoogle Scholar
• World Health Organization. Immunization coverage fact sheet. World Health Organization; Sept 2016 [accessed 2016 Dec 15]. http://www.who.int/mediacentre/factsheets/fs378/en/
   Google Scholar
• World Health Organization. Global Vaccine Action Plan 2011-2020. World Health Organization; 2013 [accessed 2016 October]. http://www.who.int/iris/bitstream/10665/78141/1/9789241504980_eng.pdf?ua = 1
   Google Scholar
• Alfonsi V, D’Ancona F, Rota MC, Giambi C, Ranghiasci A, Iannazzo S, Regional coordinators for infectious diseases and vaccinations. Immunisation registers in Italy: a patchwork of computerisation. Euro Surveill 2012; 17: pii = 20156; PMID:22551498
   PubMedGoogle Scholar
• Pebody R. Vaccine registers–experiences from Europe and elsewhere. Euro Surveill 2012; 17: pii: 20159; PMID:22551493
   PubMedGoogle Scholar
• Hellenic Center for Disease Control & Prevention. Methodology of Greek nationwide study on vaccination coverage in children aged 2 -3 years: preliminary results on vaccination against poliomyelitis. Greece: Georgakopoulou et al.; 2014 March 27 [accessed 2016 Sept 09]. http://www2.keelpno.gr/blog/?p=5189&lang=en
   Google Scholar
• Panagiotopoulos T, Papamichail D, Stafrou D, Langas D, Gavana M, Salonikioti A, Gkogkoglou B, Theocharopoulos C, Koutentakis K, Benos A, et al. National study vaccination status of children in Greece, 2012. Athens (Greece): National School of Public Health; 2013 [accessed 2016 Dec 15]. http://www.nsph.gr/files/011_Ygeias_Paidiou/Ereunes/ekthesi_emvolia_2012.pdf
   Google Scholar
• Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR, et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013; 10:e1001517; PMID:24086113; https://doi.org/10.1371/journal.pmed.1001517
   PubMed Web of Science ®Google Scholar
• Hanquet G, Perrocheau A, Kissling E, Bruhl DL, Tarrago D, Stuart J, Stefanoff P, Heuberger S, Kriz P, Vergison A, et al. Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system? Vaccine 2010; 28:3920-8; PMID:20394721; https://doi.org/10.1016/j.vaccine.2010.03.069
   PubMed Web of Science ®Google Scholar
• Grando IM, Moraes C, Flannery B, Ramalho WM, Horta MA, Pinho DL, Nascimento GL. Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil. Cad Saude Publica 2015; 31:276-84; PMID:25760162; https://doi.org/10.1590/0102-311X00169913
   PubMed Web of Science ®Google Scholar
• Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Holtzman C, Harrison LH, Zansky SM, Rosen JB, Reingold A, Scherzinger K, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study. Lancet Respir Med 2016; 4:399-406; PMID:26987984; https://doi.org/10.1016/S2213-2600(16)00052-7
   PubMed Web of Science ®Google Scholar
• Levy C, Varon E, Béchet S, Bonacorsi S, Cohen R. Long-term impact of PCV7 and PCV13 on pneumococcal meningitis in children. Presented at: 34th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2016); 2016 May 10-14; Brighton, UK.
   Google Scholar
• Tagarro A, Benito A, Sanchez A, Aznar E, Otheo E, Sanz-Rosa D, Bacteremia in Children Observation Program G. Bacteremic Pneumonia before and after Withdrawal of 13-Valent Pneumococcal Conjugate Vaccine from a Public Vaccination Program in Spain: A Case-Control Study. J Pediatr 2016; 171:111-5 e1-3; ; https://doi.org/10.1016/j.jpeds.2015.12.031
   PubMed Web of Science ®Google Scholar
• Tagarro A, Bote P, Sanchez A, Otheo E, Sanz JC, Sanz-Rosa D, Group B. Complications of Pneumococcal Bacteremia After 13-Valent Conjugate Vaccine Withdrawal. Pediatr Infect Dis J 2016; 35(12):1281-1287; PMID:27434828
   PubMed Web of Science ®Google Scholar
• Lopalco PL, Carrillo Santisteve P. Actual immunization coverage throughout Europe: are existing data sufficient? Clin Microbiol Infect 2014; 20 Suppl 5:7-11; PMID:24283205; https://doi.org/10.1111/1469-0691.12453
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Annual epidemiological report 2014 - Vaccine-preventable diseases - invasive bacterial diseases. Stockholm (Sweden): ECDC; 2015 February [accessed 2016 Dec 15]. http://ecdc.europa.eu/en/publications/Publications/AER-VPD-IBD-2014.pdf
   Google Scholar
• Savulescu C, Pastore Celentano L, Hanquet G, group S. Impact of higher-valency pneumococcal conjugate vaccination programmes on invasive pneumococcal disease incidence (2010-2014): results of a European multicentre study. Presented at: 10th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD10); 2016 June 26-30; Glasgow, Scotland.
   Google Scholar
• Grivea IN, Priftis KN, Giotas A, Kotzia D, Tsantouli AG, Douros K, Michoula AN, Syrogiannopoulos GA. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece. Vaccine 2014; 32:6513-20; PMID:25252194; https://doi.org/10.1016/j.vaccine.2014.09.016
   PubMed Web of Science ®Google Scholar
• Palmu AA, Jokinen J, Borys D, Nieminen H, Ruokokoski E, Siira L, Puumalainen T, Lommel P, Hezareh M, Moreira M, et al. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. Lancet 2013; 381:214-22; PMID:23158882; https://doi.org/10.1016/S0140-6736(12)61854-6
   PubMed Web of Science ®Google Scholar
• Tregnaghi MW, Saez-Llorens X, Lopez P, Abate H, Smith E, Posleman A, Calvo A, Wong D, Cortes-Barbosa C, Ceballos A, et al. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial. PLoS Med 2014; 11:e1001657; PMID:24892763; https://doi.org/10.1371/journal.pmed.1001657
   PubMed Web of Science ®Google Scholar
• Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Flannery B, de Oliveira LH, Santos JB, de Moraes JC, Brazilian Pneumococcal Conjugate Vaccine Effectiveness Study G. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study. Lancet Respir Med 2014; 2:464-71; PMID:24726406; https://doi.org/10.1016/S2213-2600(14)70060-8
   PubMed Web of Science ®Google Scholar
• Jokinen J, Rinta-Kokko H, Siira L, Palmu AA, Virtanen MJ, Nohynek H, Virolainen-Julkunen A, Toropainen M, Nuorti JP. Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children-a population-based study. PLoS One 2015; 10:e0120290; PMID:25781031; https://doi.org/10.1371/journal.pone.0120290
   PubMed Web of Science ®Google Scholar
• Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis 2015; 15:535-43; PMID:25801458; https://doi.org/10.1016/S1473-3099(15)70044-7
   PubMed Web of Science ®Google Scholar
• Palmu AA, Kilpi TM, Rinta-Kokko H, Nohynek H, Toropainen M, Nuorti JP, Jokinen J. Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease. Pediatrics 2015; 136:e22-7; PMID:26077477; https://doi.org/10.1542/peds.2015-0458
   PubMed Web of Science ®Google Scholar
• Del Amo E, Esteva C, Hernandez-Bou S, Galles C, Navarro M, Sauca G, Diaz A, Gassiot P, Marti C, Larrosa N, et al. Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain. PLoS One 2016; 11:e0151125; PMID:26953887; https://doi.org/10.1371/journal.pone.0151125
   PubMed Web of Science ®Google Scholar